Iovance Biotherapeutics, Inc.
2021 Q4 - 2025 Q4 (17 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/17/2026 | 23,478 | 1.2% | 8,600,000 | 12/31/2025 |
| 2025 Q3 | 11/14/2025 | 19,783 | 1.1% | 9,116,507 | 9/30/2025 |
| 2025 Q2 | 8/14/2025 | 20,330 | 1.3% | 11,820,000 | 6/30/2025 |
| 2025 Q1 | 5/15/2025 | 30,803 | 2.1% | 9,250,055 | 3/31/2025 |
| 2024 Q4 | 2/14/2025 | 37,977 | 2.9% | 5,132,000 | 12/31/2024 |
| 2024 Q3 | 11/13/2024 | 42,555 | 3.8% | 4,532,000 | 9/30/2024 |
| 2024 Q2 | 8/14/2024 | 33,139 | 3.4% | 4,132,000 | 6/30/2024 |
| 2024 Q1 | 5/14/2024 | 20,753 | 2.4% | 1,400,312 | 3/31/2024 |
| 2023 Q4 | 2/14/2024 | 17,362 | 2.2% | 2,135,521 | 12/31/2023 |
| 2023 Q3 | 11/14/2023 | 11,241 | 1.6% | 2,470,521 | 9/30/2023 |
| 2023 Q2 | 8/14/2023 | 13,213 | 2.0% | 1,876,814 | 6/30/2023 |
| 2023 Q1 | 5/17/2023 | 12,598 | 2.0% | 2,061,814 | 3/31/2023 |
| 2022 Q4 | 2/13/2023 | 13,175 | 2.2% | 2,061,814 | 12/31/2022 |
| 2022 Q3 | 11/14/2022 | 8,967 | 1.9% | 936,000 | 9/30/2022 |
| 2022 Q2 | 8/12/2022 | 17,940 | 3.6% | 1,625,000 | 6/30/2022 |
| 2022 Q1 | 5/13/2022 | 11,738 | 2.5% | 705,000 | 3/31/2022 |
| 2021 Q4 | 2/14/2022 | 10,022 | 2.7% | 525,000 | 12/31/2021 |